ALK and neuroblastoma: By studying the association of mutational variants of candidate neuroblastoma genes with clinical, cytogenetic and pathological characteristics, and survival outcomes, we found 1p candidate genes CHD5 and KIF1Bβ to be most frequently mutated after ALK, ATRX, and BARD1.